Comparison of hypolipidemic activity of synthetic gallic acid-linoleic acid ester with mixture of gallic acid and linoleic acid, gallic acid, and linoleic acid on high-fat diet induced obesity in C57BL/6 Cr Slc mice

Chemico-Biological Interactions

Volumn 174, Issue 2, 2008, Pages 109-117

  Jang, Aera ^a,d   Srinivasan, Periasamy ^b   Lee, Na Young ^c   Song, Hyun Pa ^d   Lee, Ju Woon ^b   Lee, Mooha ^e   Jo, Cheorun ^d  

^a National Institute of Animal Science   (South Korea)

^b Korea Atomic Energy Research Institute   (South Korea)

^c Chonbuk National University   (South Korea)

^d Chungnam National University   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

Gallic acid; Gallic acid linoleic acid; High fat diet; Hyperlipidemia; Linoleic acid

Indexed keywords

ANTILIPEMIC AGENT; FAT DROPLET; GALLIC ACID; GALLIC ACID LINOLEIC ACID MIXTURE; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OCTADECA 9,12 DIENYL 3,4,5 TRIHYDROXYBENZOATE; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; C57BL 6 MOUSE; CONTROLLED STUDY; CORRELATION ANALYSIS; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID DIET; LIVER WEIGHT; MOUSE; NONHUMAN; OBESITY; RISK FACTOR; SUPPLEMENTATION;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; ANTILIPEMIC AGENTS; BODY WEIGHT; CELL NUCLEUS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY FATS; DISEASE MODELS, ANIMAL; FATTY LIVER; FEMALE; GALLIC ACID; HYPERLIPIDEMIAS; LINOLEIC ACID; LIPIDS; LIVER; MICE; MICE, INBRED C57BL; OBESITY; TRIGLYCERIDES;

MUS;

EID: 46049100765     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.05.018     Document Type: Article

References (46)

1. Grundy S.M. Cholesterol and coronary heart disease. A new era. JAMA 256 (1986) 2849-2858
2. Neaton J.D., Kuller L.H., Wentworth D., and Borhani N.O. Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years. Am. Heart J. 108 (1984) 759-769
3. Tan B.K., Tan C.H., and Pushparaj P.N. Anti-diabetic activity of the semi-purified fractions of Averrhoa bilimbi in high fat diet fed-streptozotocin-induced diabetic rats. Life Sci. 76 (2005) 2827-2839
4. el-Saadany S.S., Sitohy M.Z., Labib S.M., and el-Massry R.A. Biochemical dynamics and hypocholesterolemic action of Hibiscus sabdariffa (Karkade). Nahrung 35 (1991) 567-576
5. Morishita S., Saito T., Mishima Y., Mizutani A., Hirai Y., Koyama S., and Kawakami M. Strains and species differences in experimental hyperlipidemia. Nippon Yakurigaku Zasshi 87 (1986) 259-264
6. Han L.K., Zheng Y.N., Yoshikawa M., Okuda H., and Kimura Y. Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizomes. BMC Complement Altern. Med. 5 (2005) 9
7. Devlin M.J., Yanovski S.Z., and Wilson G.T. Obesity: what mental health professionals need to know. Am. J. Psychiatry 157 (2000) 854-866
8. Fujioka K. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options. Obes. Res. 10 (2002) 116S-123S
9. Fruhbeck G., Gomez-Ambrosi J., Muruzabal F.J., and Burrell M.A. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am. J. Physiol. Endocrinol. Metab. 280 (2001) E827-E847
10. Genest J., McNamara J.R., Ordow M.J.M., Siberman S.R., Anderson K.M., Wilson P.W., Salem D.M., and Schaefer E.J. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. J. Am. Coll. Cardiol. 19 (1992) 792-802
11. Jo C., Jeong I.Y., Lee N.Y., Kim K.S., and Byun M.W. Synthesis of a novel compound from galllic acid linoleic acid and its biological functions. Food Sci. Biotechnol. 15 (2006) 317-320
12. C. Choi, Studies on investigation into biologically activated substances from Korean persimmon leaves and developing high function beverages. Report of Ministry of Agriculture and Forestry, (2000) pp. 149-150.
13. Kotani M., Matsumoto M., Fujita A., Higa S., Wang W., Suemura M., Kishimoto T., and Tanaka T. Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice. J. Allergy Clin. Immunol. 106 (2000) 159-166
14. Park S.Y., Park S.H., Jeon S.M., Park Y.B., Lee S.J., Jeong T.S., and Choi M.S. Effect of rutin and tanic acid supplements on cholesterol metabolism in rats. Nutr. Res. 22 (2002) 293-295
15. Yoshino M., Haneda M., Naruse M., Htay H.H., Iwata S., Tsubouchi R., and Murakami K. Prooxidant action of gallic acid compound: copper-dependent strand breaks and the formation of 8-hydroxy-2′-deoxyguanosine in DNA. Toxicol. In Vitro 16 (2002) 705-709
16. Baudet M.F., and Jacotot B. Dietary fat and lecithin cholesterol acyltransferase in healthy humans. Ann. Nutr. Met . 32 (1985) 352
17. Romijn D., Wiseman S.A., Scheek L.M., de Fouw N.J., and van Tol A. A linoleic acid enriched diet increases serum cholesterol esterification by lecithin:cholesterol acyltransferase in meal-fed rats. Ann. Nutr. Metab. 42 (1998) 244-250
18. Zhao G., Etherton T.D., Martin K.R., Vanden Heuvel J.P., Gillies P.J., West G.S., and Kris-Etherton P. Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cell. Biochem. Biophys. Res. Commun. 336 (2005) 909-917
19. V.J. Wacher, L.Z. Bent, Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds, US Patent 6,180,666 B1 (2001).
20. Bancroft J.D., and Gamble M. Theory and Practice of Histological Techniques. 5th edition. (2001), Churchill Livingstone, Edinburgh, UK
21. ® User's Guide: Statistics. Version 9.01 Edition (2002-2003), SAS Institute Inc., Cary, NC, USA
22. Smith Jr. S.C., Jackson R., Pearson T.A., Fuster V., Yusuf S., Faergeman O., Wood D.A., Alderman M., Horgan J., Home P., Hunn M., and Grundy S.M. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation 109 (2004) 3112-3121
23. Castelli W.B., Garrison R.J., Wilson P.W.F., Abbott R.D., Kalousdian S., and Kannel W.B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256 (1986) 2835-2838
24. Lovegrove J.A., and Jackson K.G. Coronary heart disease. In: Gibson G.R., and Williams C.M. (Eds). Functional Foods (2000), Woodhead, Cambridge 97-139
25. Anderson K.M., Wilson P.W.F., Odell P.M., and Kannel W.B. An updated coronary risk profile. A statement for health professionals. Circulation 83 (1991) 356-362
26. Berliner J.A., Navab M., Fogelma A., Frank J.S., Demer L.L., Edwards P.A., Watson A.D., and Lusis A.J. Atherosclerosis: basic mechanisms. Circulation 91 (1995) 2488-2496
27. Levine G.N., Keaney Jr. J.F., and Vita J.A. Statin therapy may be associated with lower mortality in patients with diastolic heart failure. N. Engl. J. Med. 332 (1995) 512-521
28. Bray G.A., Fisler J.S., and York D.A. Neuroendocrine control of the development of obesity: understanding gained from studies of experimental animal models. Front. Neuroendocrinol. 11 (1990) 128-181
29. Rolls B.J., Morris E.L., and Roe L.S. Portion size of food affects energy intake in normal-weight and overweight men and women. Am. J. Clin. Nutr. 76 (2002) 1207-1213
30. Baba D.H., Sultan R., Cortas N., and Habbal Z. Diet composition affects weight gain, adiposity and blood parameters in healthy human volunteers. Nutr. Res. 19 (1999) 1313-1326
31. Jequier E., and Tappy L. Regulation of body weight in humans. Physiol. Rev. 79 (1999) 451-480
32. Marette A., Gavino V.C., and Nadeau M.H. Effects of dietary saturated and polyunsaturated fats on adipose tissue lipoprotein lipase activity. Nutr. Res. 10 (1990) 683-695
33. West D.B., and York B. Dietary fat, genetic predisposition, and obesity: lessons from animal models. Am. J. Clin. Nutr. 67 (1998) 505S-512S
34. Jahromi F., Ray A.B., and Chansouria J.P.N. Antihyperlipidemic effect of flavonoids from Pterocarpus marsupium. J. Nat. Prod. 56 (1993) 989-994
35. Moon H.S., Lee H.G., Choi Y.J., Kim T.G., and Cho C.S. Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity. Chem. Biol. Interact. 167 (2007) 85-98
36. Abe I., Seki T., Umehara K., Miyase T., Noguchi H., Sakakibara J., and Ono T. Green tea polyphenols: novel and potent inhibitors of squalene epoxidase. Biochem. Biophys. Res. Commun. 268 (2000) 767-771
37. Wu B.T., Hung P.F., Chen H.C., Huang R.N., Chang H.H., and Kao Y.H. The apoptotic effect of green tea (-)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the Cdk2 pathway. J. Agric. Food Chem. 53 (2005) 5695-5701
38. Jones J.D., and Chambliss M.L. Hypertriglyceridemia and coronary heart disease. Arch. Fam. Med. 9 (2000) 189-190
39. Hopkins P.N., Wu L.L., Hunt S.C., and Brinton E.A. Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary arterydisease. J. Am. Coll. Cardiol. (2005) 1003-1012
40. Nenseter M.S., Gudmundsen O., Malterud K.E., Berg T., and Drevon C.A. Effect of cholesterol feeding on the susceptibility of lipoproteins to oxidative modification. Biochim. Biophys. Acta 1213 (1994) 207-214
41. Steinberg D. Antioxidant vitamins and coronary heart disease. N. Engl. J. Med. 328 (1993) 1487-1489
42. The Expert Panel. The role of triglycerides as a CHD risk factor. JAMA 269 (1993) 3015-3023
43. Schaefer E.J., Lichtenstein A.H., Lamon-Fava S., McNamara J.R., and Ordovas J.M. Lipoproteins, nutrition, aging, and atherosclerosis. Am. J. Clin. Nutr. 61 (1995) 726S-740S
44. Stein O., and Stein Y. Atheroprotective mechanisms of HDL. Atherosclerosis 144 (1999) 285-301
45. Festi D., Colecchia A., Sacco T., Bondi M., Roda E., and Marchesini G. Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obesity Rev. 5 (2004) 27-42
46. Lee M.S. Effects of high polyunsaturated fat diet on human plasma cholesterol esterification and transfer. Korean J. Nutr. 26 (1993) 819-828